Fusion Pharmaceuticals, a member of the AstraZeneca Group,is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha
Charles River Analytics, a GRVTY company, creates solutions and technology to tackle the world’s most challenging problems. Our team of technological entrepreneurs works together to push at the forefront of enhanced AI, robotics, smart sensing, and